Could hydrogen sulfide be the next blockbuster treatment for inflammatory disease?

Expert Review of Clinical Pharmacology

Volumn 6, Issue 6, 2013, Pages 593-595

  Li, Ling ^a   Moore, Philip K ^b  

^a p53 Laboratory   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

cystathionine g lyase; GYY4137; hydrogen sulphide; inflammation; S propargylcysteine

Indexed keywords

3 MERCAPTOPYRUVIC ACID; CYSTATHIONINE BETA SYNTHASE; DICLOFENAC; GYY 4137; HYDROGEN SULFIDE; INTERLEUKIN 6; MESALAZINE; NAPROXEN; NITRIC OXIDE; S PROPARGYLCYSTEINE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BIOSYNTHESIS; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MEDIATOR; NONHUMAN; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; MICE;

EID: 84887309655     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/17512433.2013.842126     Document Type: Review

References (15)

1. Zhu XY, Liu SJ, Liu YJ, Wang S, Ni X. Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide- treated macrophages. Cell. Mol. Life Sci. 67(7), 1119-1132 (2010).
2. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid. Redox Signal. 12(10), 1147-1154 (2010).
3. Li L, Rose P, Moore PK. The biological significance of hydrogen sulfide. Ann. Rev. Pharmacol. 51, 169-187 (2011).
4. Wallace JL, Ferraz JG, Muscara MN. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid. Redox Signal. 17(1), 58-67 (2012).
5. Alshorafa AK, Guo Q, Zeng F Psoriasis is associated with low serum levels of hydrogen sulfide, a potential antiinflammatory molecule. Tohoku. J. Exp. Med. 228, 325-332 (2012).
6. di Villa Bianca RD, Coletta C, Mitidieri E. Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2. Br. J. Pharmacol. 161(8), 1835-1842 (2010).
7. Bhatia M, Sidhapuriwala J, Moochhala SM, Moore, PK. Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat. Br. J. Pharmacol. 145(2), 141-144 (2005).
8. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEBJ 20(12), 2118-2120 (2006).
9. Kashfi K, Olson KR. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem. Pharmacol. 85(5), 689-703 (2013).
10. Shirozu K, Tokuda K, Marutani E, Lefer D, Wang R, Ichinose F. Cystathionine g-lyase deficiency protects mice from galactosamine/ lipopolysaccharide-induced acute liver failure. Antioxid. Redox Signal. doi:10.1089/ ars.2013.5354 (2013) (Epub ahead of print).
11. Shen X, Pattillo CB, Pardue S, Bir SC, Wang R, Kevil CG. Measurement of plasma hydrogen sulfide in vivo and in vitro. Free Radic. Biol. Med. 50(9), 1021-1031 (2011).
12. Nishida M, Sawa T, Kitajima N, Ono K Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration. Nat. Chem. Biol. 8(8), 714-724 (2012).
13. Fiorucci S, Orlandi S, Mencarelli A Enhanced activity of a hydrogen sulphidereleasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol. 150(8), 996-1002 (2007).
14. Wallace JL, Caliendo G, Santagada V, Cirino G, Fiorucci S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology 132(1), 261-271 (2007).
15. Wallace JL, Caliendo G, Santagada V, Cirino G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br. J. Pharmacol. 159(6), 1236-1246 (2010).